Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Aug 29, 2019 (7 years ago)

Fexofenadine HCl Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Impurities/Degradation Specifications

Cause type: Impurity / degradation

An impurity or degradation product above its limit - other than nitrosamines. Unexpected substances in a batch can make it unsafe or less effective, even when the active ingredient is present. All impurity / degradation recalls.

What was recalled

Fexofenadine HCl Tablets, 180 mg, Pkg Size 90, Mfg: Aurohealth LLC, Repackaged by Preferred Pharmaceuticals, Inc., Anaheim, CA, NDC #: 68788-6848-09

Affected NDC 68788-6848-09

Compare with the code on your package — it is the most precise check available.

Drug: Fexofenadine Category: Allergy & Cold Medication

Recalling firm
Preferred Pharmaceuticals, Inc
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1877-2019 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Fexofenadine recalls

See all
Class II · Moderate risk

Fexofenadine Hydrochloride Tablets

CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Completed Microbial contamination Sun Pharmaceutical Industries INC NDC 51660-998-30 D-0273-2024
Class II · Moderate risk

Allergy Relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation L. Perrigo Company NDC 36800-691-39 D-0912-2023
Class II · Moderate risk

Picnic

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation L. Perrigo Company D-0911-2023
Class II · Moderate risk

allergy relief

Failed Impurities/Degradation Specifications

Terminated Impurity / degradation L. Perrigo Company NDC 11673-617-22 D-0910-2023

Other recalls by Preferred Pharmaceuticals, Inc

All 2019 recalls
Class II · Moderate risk

Ondansetron ODT Tablets

Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.

Ongoing Packaging defect Preferred Pharmaceuticals, Inc. NDC 68788-8666-01 D-0239-2026
Class II · Moderate risk

Ibuprofen Tablets

Failed Impurities/Degradation Specifications - at 18-month Stability testing

Ongoing Impurity / degradation Preferred Pharmaceuticals, Inc. NDC 68788-9110-03 D-0647-2024